Michael McCullar, CEO and Hong Tang, Co-Founder and Chief Medical Officer OnQuality Pharmaceuticals describe the pipeline they are building to address unmet clinical needs in the area of oncology supportive care for skin rashes such as Hand-Foot Skin Reaction and GI toxicities like chemotherapy-induced diarrhea.  As leaders in the emerging oncodermatology and oncogastroenterology fields, the […]

Gurus you will love the value that Jim Archetto brings. He has held leadership positions in several Innovative companies with some amazing technologies. Jim is passionate about bring innovation to clinicians so they can improve patient outcomes. He brings many insights into how to commercialize a product. You will love his discussion around making sure […]

180 Life Sciences: ATNF CEO, Jim Woody, says that the company is focused on drug development that fulfills unmet needs in inflammatory diseases. It seeks to develop novel drugs addressing separate areas of inflammation. What is next for 180 Life Sciences and how will the stock price be affected?